Johnson & Johnson Registers Strong Fourth Quarter Performance; 2014 Outlook Conservative
Johnson & Johnson (JNJ) has built one of the most comprehensive bases of health care businesses and generates an impressive 70% of revenue from top positions in the respective markets in which it operates. The health care and consumer giant remains focused on innovation and generating incremental revenue from new products as it broadens its geographic presence. Johnson & Johnson’s fourth-quarter performance, released Tuesday, showed that it continues to execute at a very high level. The company’s sales advanced 4.5% in the fourth quarter (6.3% excluding currency) thanks to strong top-line performance in its pharmaceutical division, which witnessed revenue expand more than 13%, excluding the impact from currency. Domestic sales leapt 7.4%, while international sales increased 2.4% (5.6% excluding currency). … Read more